AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Eurepa 0.5 Tablet

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Repaglinide (0.5mg)

Overview Eurepa 0.5 Tablet

Diabetac 0.5mg tablets are indicated for managing elevated blood glucose in adult patients with type 2 diabetes. This medication is typically prescribed adjunctively with other antidiabetic agents to optimize glycemic control and mitigate the risk of severe diabetic complications, such as nephropathy and retinopathy. Diabetac 0.5mg is generally introduced when dietary modifications, exercise, and/or alternative therapies prove insufficient in regulating blood sugar. Optimal efficacy is achieved with pre-meal administration. Dosage is individualized based on patient response and glycemic readings, always as directed by a physician. Consistent, daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar management contributes to preventing future complications. Adherence to the prescribed diet and exercise regimen is crucial for successful diabetes management. Lifestyle factors are integral to overall diabetes control. Hypoglycemia (low blood sugar) is the most frequently reported adverse effect; carrying glucose tablets can help manage this. Other potential side effects include gastrointestinal upset (abdominal pain, nausea, diarrhea), sinusitis, arthralgia, and back pain. Report any persistent or concerning side effects to your doctor. Prior to initiating treatment, inform your doctor of any pre-existing kidney, cardiac, or pancreatic conditions, significant alcohol consumption, or pregnancy/breastfeeding. Concurrent medications may interact; disclose all medications to your physician. Alcohol consumption should be limited due to the increased hypoglycemia risk. Regular monitoring of renal function and blood glucose levels is necessary to assess treatment efficacy.

Uses of Eurepa 0.5 Tablet

Managing type 2 diabetes

Major Benefits of Eurepa 0.5 Tablet:

Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Eurepa 0.5 Tablet on an empty stomach.

Common Side effects of Eurepa 0.5 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Abdominal pain
  • Nausea
  • Diarrhea
  • Back pain
  • Joint pain
  • Upper respiratory tract infection
  • Headache
  • Sinus inflammation

How to use Eurepa 0.5 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Eurepa 0.5 Tablet whole; do not crush, chew, or break it. Administer on an empty stomach.

How Eurepa 0.5 Tablet works:

Diabetics may use Eurepa 0.5mg tablets to manage their blood sugar. This medication stimulates pancreatic insulin secretion, thus moderating postprandial hyperglycemia.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Eurepa 0.5 Tablet and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Eurepa 0.5 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Eurepa 0.5 Tablet while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with severe renal impairment should exercise caution when using Eurepa 0.5 Tablet; dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Eurepa 0.5mg tablets; dosage modification may be necessary. Medical advice is recommended. Eurepa 0.5mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Eurepa 0.5 Tablet :

Omit any missed Eurepa 0.5 Tablet dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Eurepa 0.5 Tablet

LabelValue
Chemical Type Meglitinides
Developing Habits No.
Treatment Category Diabetes Management
Behavioral Class Insulin Secretagogues (Meglitinides)

FAQs on Eurepa 0.5 Tablet

Eurepa 0.5 Tablet begins working within 30 minutes of ingestion, raising insulin levels and subsequently lowering blood sugar. This effect typically persists for four hours.
Avoid alcohol while using Eurepa 0.5 Tablet, as it can interfere with its effects and cause low blood sugar. Symptoms of low blood sugar may include weakness, shakiness, cold sweats, pale skin, rapid heartbeat, tremors, intense hunger, dizziness, headache, and anxiety.
Yes, it may be used alongside other antidiabetic medications, as directed by your physician. However, given the combined blood sugar-lowering effect, regular blood glucose monitoring is crucial.
Breastfeeding is not advised while taking Eurepa 0.5 Tablet, as the medication may transfer into breast milk and cause potentially harmful low blood sugar in your baby. Consult your doctor for guidance.
Consult your doctor regarding clopidogrel use with Eurepa 0.5 Tablet. If use is unavoidable, take 0.5 mg Eurepa 0.5 Tablet before each meal, not exceeding 4 mg daily. Closely monitor your blood sugar.
Eurepa 0.5 Tablet
146
MRP 169
13% off